Cargando…

克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656080/
https://www.ncbi.nlm.nih.gov/pubmed/33190444
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.10.011
_version_ 1783608306634326016
collection PubMed
description
format Online
Article
Text
id pubmed-7656080
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-76560802020-11-13 克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2020-10 /pmc/articles/PMC7656080/ /pubmed/33190444 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.10.011 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响
title 克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响
title_full 克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响
title_fullStr 克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响
title_full_unstemmed 克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响
title_short 克隆性基因突变对接受强化巩固治疗的CBFβ-MYH11融合基因阳性急性髓系白血病预后的影响
title_sort 克隆性基因突变对接受强化巩固治疗的cbfβ-myh11融合基因阳性急性髓系白血病预后的影响
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656080/
https://www.ncbi.nlm.nih.gov/pubmed/33190444
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.10.011
work_keys_str_mv AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng
AT kèlóngxìngjīyīntūbiànduìjiēshòuqiánghuàgǒnggùzhìliáodecbfbmyh11rónghéjīyīnyángxìngjíxìngsuǐxìbáixuèbìngyùhòudeyǐngxiǎng